288 related articles for article (PubMed ID: 10636161)
1. Botulinum toxin A as treatment for drooling saliva in PD.
Pal PK; Calne DB; Calne S; Tsui JK
Neurology; 2000 Jan; 54(1):244-7. PubMed ID: 10636161
[TBL] [Abstract][Full Text] [Related]
2. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
Savarese R; Diamond M; Elovic E; Millis SR
Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin for treatment of parkinsonian sialorrhea.
Friedman A; Potulska A
Neurol Neurochir Pol; 2001; 35 Suppl 3():23-7. PubMed ID: 12001650
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin injections for children with excessive drooling.
Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B
J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177
[TBL] [Abstract][Full Text] [Related]
5. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of botulinum toxin A for treatment of drooling.
Lipp A; Trottenberg T; Schink T; Kupsch A; Arnold G
Neurology; 2003 Nov; 61(9):1279-81. PubMed ID: 14610139
[TBL] [Abstract][Full Text] [Related]
7. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease.
Ondo WG; Hunter C; Moore W
Neurology; 2004 Jan; 62(1):37-40. PubMed ID: 14718694
[TBL] [Abstract][Full Text] [Related]
8. Saliva changes in Parkinson's disease patients after injection of Botulinum neurotoxin type A.
Tiigimäe-Saar J; Tamme T; Rosenthal M; Kadastik-Eerme L; Taba P
Neurol Sci; 2018 May; 39(5):871-877. PubMed ID: 29460161
[TBL] [Abstract][Full Text] [Related]
9. Quantitative reduction of saliva production with botulinum toxin type B injection into the salivary glands.
Turk-Gonzales M; Odderson IR
Neurorehabil Neural Repair; 2005 Mar; 19(1):58-61. PubMed ID: 15673844
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
Wilken B; Aslami B; Backes H
Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
[TBL] [Abstract][Full Text] [Related]
12. Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins.
Narayanaswami P; Geisbush T; Tarulli A; Raynor E; Gautam S; Tarsy D; Gronseth G
Parkinsonism Relat Disord; 2016 Sep; 30():73-7. PubMed ID: 27406786
[TBL] [Abstract][Full Text] [Related]
13. Treatment of drooling in Parkinson's disease with botulinum toxin.
Jost WH
Mov Disord; 1999 Nov; 14(6):1057. PubMed ID: 10584695
[No Abstract] [Full Text] [Related]
14. Repeated treatments of drooling with botulinum toxin B in neurology.
Møller E; Daugaard D; Holm O; Winge K; Bardow A; Lykkeaa J; Belhage B; Bakke M
Acta Neurol Scand; 2015 Jan; 131(1):51-7. PubMed ID: 25270197
[TBL] [Abstract][Full Text] [Related]
15. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
Gonzalez-L MD; Martinez C; Bori Y Fortuny I; Suso-Vergara S
Am J Phys Med Rehabil; 2017 Feb; 96(2):68-76. PubMed ID: 28099276
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease.
Dogu O; Apaydin D; Sevim S; Talas DU; Aral M
Clin Neurol Neurosurg; 2004 Mar; 106(2):93-6. PubMed ID: 15003297
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin A as a treatment for excessive drooling in children.
Bothwell JE; Clarke K; Dooley JM; Gordon KE; Anderson R; Wood EP; Camfield CS; Camfield PR
Pediatr Neurol; 2002 Jul; 27(1):18-22. PubMed ID: 12160968
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin is a useful treatment in excessive drooling in saliva.
Bhatia KP; Münchau A; Brown P
J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):697. PubMed ID: 10577041
[No Abstract] [Full Text] [Related]
19. Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling.
Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
J Neurol; 2009 Apr; 256(4):563-7. PubMed ID: 19401804
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin-A injections vs radiotherapy for drooling in ALS.
Weikamp JG; Schinagl DA; Verstappen CC; Schelhaas HJ; de Swart BJ; Kalf JG
Acta Neurol Scand; 2016 Sep; 134(3):224-31. PubMed ID: 26803950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
